Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 3,129,501 | 3,211,462 | 3,092,773 | 3,088,193 | 2,878,096 |
| Cost of Goods | 599,949 | 565,440 | 617,690 | 598,100 | 571,650 |
| Gross Profit | 2,529,552 | 2,727,279 | 2,523,390 | 2,490,080 | 2,306,430 |
| Operating Expenses | 1,404,826 | 1,583,240 | 1,477,940 | 1,492,750 | 1,313,420 |
| Operating Income | 1,125,676 | 1,063,222 | 997,833 | 997,443 | 993,676 |
| Interest Expense | 66,113 | 0 | 0 | 0 | 0 |
| Other Income | 8,286 | -8,282 | 38,807 | 38,577 | -23,496 |
| Pre-tax Income | 1,067,849 | 1,054,940 | 1,036,640 | 1,036,020 | 970,180 |
| Income Tax | 245,586 | 202,550 | 238,450 | 238,160 | 223,190 |
| Net Income Continuous | 822,263 | 831,046 | 785,915 | 797,862 | 746,988 |
| Net Income | $822,263 | $831,046 | $785,915 | $797,862 | $746,988 |
| EPS Basic Total Ops | 0.15 | 0.15 | 0.14 | 0.14 | 0.13 |
| EPS Basic Continuous Ops | 0.15 | 0.15 | 0.14 | 0.14 | 0.13 |
| EPS Diluted Total Ops | 0.15 | 0.15 | 0.14 | 0.14 | 0.13 |
| EPS Diluted Continuous Ops | 0.15 | 0.15 | 0.14 | 0.14 | 0.13 |
| EBITDA(a) | $1,125,675 | $674,672 | $1,110,393 | $1,162,483 | $1,104,626 |